<DOC>
	<DOCNO>NCT01509534</DOCNO>
	<brief_summary>Study hypothesis : Dual-chamber pacemaker therapy rate-hysteresis feature effective prevent syncopal recurrence patient affected cardioinhibitory ( CI ) form reflex syncope diagnose mean carotid sinus massage , tilt table test implantable loop recorder ( ILR ) . The outcome measure either time first syncopal recurrence total syncope burden .</brief_summary>
	<brief_title>Guideline-based Pacing Therapy Reflex Syncope</brief_title>
	<detailed_description>Background Divergence opinion exist regard efficacy cardiac pacing patient affect different form reflex syncope . Definitions . Severe syncope define : - perceive patient alters his/her quality life , - unpredictable occurs without , short prodrome &lt; 10 sec ( thus expose patient risk trauma ) , precede prodrome , syncope recurs despite appropriate therapy ( CPM drug ) . Recurrent syncope : least 2 episode last year ( include index episode ) 3 episode last 2 year ( include index episode ) . Suspected ( undetermined ) reflex syncope : suspicion reflex syncope base history uncertain syncope absence ( ) severe structural heart disease , significant ECG abnormality , rhythm disturbance ; ( ii ) orthostatic hypotension ; ( iii ) non-syncopal cause transient loss consciousness . Study protocol 1 . The eligible patient undergo firstly carotid sinus massage ( accord method symptom ) ; diagnosis cardioinhibitory carotid sinus syndrome ( CI-CSS ) make , pacemaker implant follow-up immediately start . 2 . If carotid sinus massage negative vasodepressor , patient undergo tilt table testing ( nitroglycerin clomipramine drug challenge ) ; diagnosis VASIS 2B form make , pacemaker implant follow-up immediately start . 3 . If tilt table test negative form different VASIS 2B induce , patient undergo ILR implantation . If diagnosis asystolic reflex syncope make , pacemaker implant follow-up immediately start . End-points End-point study syncope recurrence pacemaker ( PM ) implantation . Syncope define complete transient loss consciousness . Pre-syncope count end-point . Primary end-points : 1 . Comparison time first syncopal recurrence CI-CSS CI-TTT pt PM control patient ILR . 2 . Intra-patient comparison syncope burden year year follow PM implant patient receive PM ( CCS , TTT ILR group ) . Index syncope count . Follow-up One year PM implantation enrol patient burden syncope end-points Until study end time first syncope recurrence end-points . Thus , study end one year enrollment last patient . Study size Based sample size calculation study stop 700 patient enrol .</detailed_description>
	<mesh_term>Syncope</mesh_term>
	<mesh_term>Syncope , Vasovagal</mesh_term>
	<criteria>Patients affect severe , recurrent , certain suspect ( undetermined ) reflex syncope , age â‰¥ 40 year . Reflex syncope due reversible cause , e.g. , vasoactive drug , concomitant disease , etc Suspected certain cardiac syncope Syncope cause orthostatic hypotension Nonsyncopal cause transient loss consciousness</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>pacemaker</keyword>
	<keyword>implantable loop recorder</keyword>
	<keyword>syncope</keyword>
</DOC>